Guardion Health Sciences, Inc.

GHSI

US40145Q5009

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:30:00 14/06/2024 BST			5-day change	1st Jan Change
10.08 ^USD	-0.15%		+1.87%	+88.86%

05-31	Doctor's Best, Inc. completed the acquisition of Activ Nutritional, LLC. from Guardion Health Sciences, Inc..	CI
05-13	Guardion Health Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Guardion Health Sciences, Inc. Announces Resignation of Vincent Roth as General Counsel

October 07, 2020 at 09:07 pm

Effective October 1, 2020, Guardion Health Sciences, Inc. announced that Vincent Roth ceased to be employed as general counsel of company, Mr. Roth did not depart as a result of any disagreement with the company relating to the company's operations, policies or practices.

Latest news about Guardion Health Sciences, Inc.

Doctor's Best, Inc. completed the acquisition of Activ Nutritional, LLC. from Guardion Health Sciences, Inc..	05-30	CI
Guardion Health Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-13	CI
Guardion Health Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-29	CI
North American Morning Briefing : Hopes of March -2-	02-05	DJ
Maxim Downgrades Guardion Health Sciences to Hold From Buy	02-02	MT
Top Midday Gainers	01-31	MT
Alphabet Earnings, Upcoming Fed Rate Decision Drive Mixed Premarket Action for US Equity Futures	01-31	MT
Top Premarket Gainers	01-31	MT
Doctor's Best, Inc. agreed to acquire Activ Nutritional, LLC. from Guardion Health Sciences, Inc. for $17.2 million.	01-29	CI
Guardion Health Sciences Continues its Strategic Review Process	11-13	CI
Guardion Health Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Guardion Health Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Guardion Health Sciences, Inc. Announces Executive Changes	31/07/23	CI
US Stock Futures Trend Higher Ahead of Consumer Sentiment Report	30/06/23	MT
Top Premarket Decliners	30/06/23	MT
Guardion Health Sciences, Inc. Announces Executive Changes	30/05/23	CI
Guardion Health Sciences, Inc. Announces CEO Changes	30/05/23	CI
Guardion Health Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Guardion Health Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	17/04/23	CI
Guardion Health Sciences Hires Alantra, LLC as Financial Advisor to Explore Strategic Alternatives to Maximize Stockholder Value	06/03/23	CI
Guardion Health Sciences Regains Compliance With Nasdaq Listing Rules	25/01/23	MT
Insider Buy: Guardion Health Sciences	11/01/23	MT
Guardion Health Sciences, Inc. announced that it expects to receive $4.75 million in funding	28/11/22	CI
Guardion Health Sciences Engages Financial Advisor to Conduct a Strategic Review Process	14/11/22	CI
Guardion Health Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI

Chart Guardion Health Sciences, Inc.

Duration

Period

More charts

Company Profile

Guardion Health Sciences, Inc. is a clinical nutrition company. The Company offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The Company sells two ocular products: GlaucoCetin and Lumega-Z. GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health. Lumega-Z, its medical food product, has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. As a medical food, Lumega-Z must be administered under the supervision of a physician or professional healthcare provider. It sells GlaucoCetin and Lumega-Z on its Website, guardionhealth.com.

Sector

Pharmaceuticals

Calendar

11/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
GUARDION HEALTH SCIENCES, INC.	+88.86%	12.95M
NOVO NORDISK A/S	+41.96%	630B
JOHNSON & JOHNSON	-7.15%	350B
MERCK & CO., INC.	+18.77%	328B
ABBVIE INC.	+8.79%	298B
ASTRAZENECA PLC	+18.02%	246B
ROCHE HOLDING AG	+1.27%	225B
NOVARTIS AG	+11.95%	218B
AMGEN INC.	+3.68%	160B
PFIZER, INC.	-4.38%	156B

Other Pharmaceuticals